Marco et al. [81] found that the delivery of oligonucleotides through modified nanomaterials can overcome the cancer resistance of refractory tumors carrying Mut p53 apoptosis because these nanostructures can inhibit the mTOR signaling pathway and anti-apoptotic protein Bcl-2. Here, MTOR is linked to cancer.